Expert Insights on Biotech Industry

The Biotech Industry is the business sector encompassing the production and use of living organisms or active components to make or modify commercial products. This process is the predominant focus of organizations known as biotechnology companies.

Gerson Lehrman Group Council Members are available to discuss Biotech Industry via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Peter Culpepper, Chief Financial Officer, Provectus Pharmaceuticals, Inc.

Peter Culpepper What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Chief Financial OfficerProvectus Pharmaceuticals, Inc.

Vasilios Voudouris, Chief Executive Officer, Vereniki Solutions

Vasilios Voudouris What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Chief Executive OfficerVereniki Solutions

Eric Gruff, Principal, E4 Consulting

Eric Gruff What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

PrincipalE4 Consulting

Peter Culpepper, Chief Financial Officer, Provectus Pharmaceuticals, Inc.

Peter Culpepper What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Chief Financial OfficerProvectus Pharmaceuticals, Inc.

Vasilios Voudouris, Chief Executive Officer, Vereniki Solutions

Vasilios Voudouris What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Chief Executive OfficerVereniki Solutions

Browse all 364 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
High Pressure Liquid Chromatography Users (US) 37
Paroxysmal Nocturnal Hemoglobinuria Experts (EU) 28
Affymetrix 500K SNP Chip Users (US) 50
Current or Former Chief Financial Officers in the Pharmaceuticals & Biotechnology Manufacturing and Research Industry 106
Agricultural Economics Experts (US) 38

Browse all 981 Study Groups

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Biocon & the Indian Biotech story!!!

September 14, 2009

GLG Expert Contributor

Europe in a Bind Over Biotech Policy

August 24, 2009

John Baize, President, John C. Baize & Associates

Europe in a Bind Over Biotech Policy

August 21, 2009

John Baize, President, John C. Baize & Associates

Panacea the Next Big Biotech player

August 20, 2009

GLG Expert Contributor

Browse all 8743 GLG News Analyses

Contact Gerson Lehrman Group to engage a Biotech Industry expert